Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Dorner

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Annals of the New York Academy of Sciences|January 4, 2012
Deconstructing hepatitis C virus infection in humanized miceMarcus Dorner, Alexander Ploss
Virology|April 8, 2015
Advances in experimental systems to study hepatitis C virus in vitro and in vivoMaria Teresa Catanese, Marcus Dorner
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2018
Modeling Unique Patients in Humanized Mice: Toward a Curative Strategy for HIVMarcus Dorner, Ype P de Jong
Vaccines|September 2, 2017
Immune Evasion Strategies during Chronic Hepatitis B and C Virus InfectionAna Maria Ortega-Prieto, Marcus Dorner
Methods (San Diego, Calif.)|June 13, 2012
Study of hepatitis C virus entry in genetically humanized miceMarcus Dorner, Charles M Rice, Alexander Ploss
Immunology|February 16, 2018
A Hitchhiker's guide to humanized mice: new pathways to studying viral infectionsJessica Katy Skelton, Ana Maria Ortega-Prieto, Marcus Dorner
ACS Infectious Diseases|December 13, 2018
In Vivo Model Systems for Hepatitis B Virus ResearchAna Maria Ortega-Prieto, Catherine Cherry, Harry Gunn, et al.
Current Topics in Microbiology and Immunology|March 7, 2013
Animal models for hepatitis CEva Billerbeck, Ype de Jong, Marcus Dorner, et al.
Blood|January 22, 2011
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized miceEva Billerbeck, Walter T Barry, Kathy Mu, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 9, 2019
Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infectionAntonia Alexandra Evripioti, Ana Maria Ortega-Prieto, Jessica Katy Skelton, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Annals of the New York Academy of Sciences|January 4, 2012
Deconstructing hepatitis C virus infection in humanized miceMarcus Dorner, Alexander Ploss
Virology|April 8, 2015
Advances in experimental systems to study hepatitis C virus in vitro and in vivoMaria Teresa Catanese, Marcus Dorner
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2018
Modeling Unique Patients in Humanized Mice: Toward a Curative Strategy for HIVMarcus Dorner, Ype P de Jong
Vaccines|September 2, 2017
Immune Evasion Strategies during Chronic Hepatitis B and C Virus InfectionAna Maria Ortega-Prieto, Marcus Dorner
Methods (San Diego, Calif.)|June 13, 2012
Study of hepatitis C virus entry in genetically humanized miceMarcus Dorner, Charles M Rice, Alexander Ploss
Immunology|February 16, 2018
A Hitchhiker's guide to humanized mice: new pathways to studying viral infectionsJessica Katy Skelton, Ana Maria Ortega-Prieto, Marcus Dorner
ACS Infectious Diseases|December 13, 2018
In Vivo Model Systems for Hepatitis B Virus ResearchAna Maria Ortega-Prieto, Catherine Cherry, Harry Gunn, et al.
Current Topics in Microbiology and Immunology|March 7, 2013
Animal models for hepatitis CEva Billerbeck, Ype de Jong, Marcus Dorner, et al.
Blood|January 22, 2011
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized miceEva Billerbeck, Walter T Barry, Kathy Mu, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 9, 2019
Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infectionAntonia Alexandra Evripioti, Ana Maria Ortega-Prieto, Jessica Katy Skelton, et al.
Pageof 5